In fact, the eventual damage of high-pressure baroreceptors, responsible for the physiological AVP release inhibition, together with the SIRS-related dysregulation in V1R and NPR may be implicated in the observed increase in copeptin and NT-proBNP levels. The gene discussed is NPPB; the disease is systemic inflammatory response syndrome.